| Primary |
| Type 2 Diabetes Mellitus |
57.5% |
| Diabetes Mellitus |
12.2% |
| Hypertension |
11.4% |
| Dyslipidaemia |
2.8% |
| Procedural Complication |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Bipolar Disorder |
1.7% |
| Atrial Fibrillation |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hypercholesterolaemia |
1.1% |
| Polyarthritis |
1.1% |
| Neuropathy Peripheral |
0.8% |
| Prophylaxis |
0.8% |
| Angina Pectoris |
0.6% |
| Anxiety |
0.6% |
| Cardiovascular Event Prophylaxis |
0.6% |
| Coronary Artery Disease |
0.6% |
| Depression |
0.6% |
| Hyperlipidaemia |
0.6% |
| Neuralgia |
0.6% |
|
| Hypoglycaemia |
11.5% |
| Pancreatic Carcinoma |
11.5% |
| Vomiting |
8.2% |
| Cerebrovascular Accident |
6.6% |
| Overdose |
6.6% |
| Cerebral Haemorrhage |
4.9% |
| Death |
4.9% |
| Dyspnoea |
4.9% |
| Sepsis |
4.9% |
| Anaemia |
3.3% |
| Chronic Lymphocytic Leukaemia |
3.3% |
| Drug Eruption |
3.3% |
| Hospitalisation |
3.3% |
| Interstitial Lung Disease |
3.3% |
| Intestinal Obstruction |
3.3% |
| Large Intestine Carcinoma |
3.3% |
| Lung Neoplasm Malignant |
3.3% |
| Myocardial Infarction |
3.3% |
| Off Label Use |
3.3% |
| Pancreatitis |
3.3% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
30.9% |
| Diabetes Mellitus |
17.7% |
| Product Used For Unknown Indication |
17.2% |
| Hypertension |
11.5% |
| Drug Use For Unknown Indication |
2.4% |
| Bipolar Disorder |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Anxiety |
2.1% |
| Pain |
2.1% |
| Dyslipidaemia |
1.9% |
| Cardiac Failure |
1.5% |
| Asthma |
1.0% |
| Constipation |
1.0% |
| Diabetic Neuropathy |
1.0% |
| Hypertriglyceridaemia |
1.0% |
| Insomnia |
1.0% |
| Cerebral Infarction |
0.9% |
| Irritability |
0.9% |
| Acute Coronary Syndrome |
0.7% |
| Atrial Fibrillation |
0.7% |
|
| Pancreatic Carcinoma |
9.8% |
| Abdominal Pain Upper |
7.3% |
| Hypoglycaemia |
7.3% |
| Ketoacidosis |
7.3% |
| Vomiting |
6.1% |
| Granulomatous Liver Disease |
4.9% |
| Hepatic Cirrhosis |
4.9% |
| Lipase Increased |
4.9% |
| Rectal Haemorrhage |
4.9% |
| Renal Failure Acute |
4.9% |
| Wrong Technique In Drug Usage Process |
4.9% |
| Blood Pressure Diastolic Decreased |
3.7% |
| Circulatory Collapse |
3.7% |
| Cytolytic Hepatitis |
3.7% |
| Dehydration |
3.7% |
| Drug Eruption |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Nephropathy |
3.7% |
| Overdose |
3.7% |
| Pneumonia Mycoplasmal |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.8% |
| Diabetes Mellitus |
18.5% |
| Hypertension |
11.8% |
| Product Used For Unknown Indication |
10.2% |
| Type 2 Diabetes Mellitus |
8.3% |
| Hepatitis C |
4.4% |
| Rheumatoid Arthritis |
4.0% |
| Schizophrenia |
3.2% |
| Prophylaxis |
3.1% |
| Blood Cholesterol Increased |
2.3% |
| Hyperlipidaemia |
1.6% |
| Constipation |
1.5% |
| Pain |
1.5% |
| Depression |
1.5% |
| Insomnia |
1.2% |
| Cancer Pain |
1.2% |
| Hypercholesterolaemia |
1.1% |
| Blood Cholesterol |
1.0% |
| Breast Cancer |
1.0% |
| Back Pain |
1.0% |
|
| Anaemia |
7.3% |
| Loss Of Consciousness |
7.3% |
| Tremor |
7.3% |
| Myalgia |
6.6% |
| Blood Glucose Increased |
5.8% |
| Pruritus |
5.8% |
| Myocardial Infarction |
5.1% |
| Rash |
5.1% |
| Somnolence |
5.1% |
| White Blood Cell Count Decreased |
5.1% |
| Diabetes Mellitus |
4.4% |
| Hypoglycaemia |
4.4% |
| Pneumonia |
4.4% |
| Renal Impairment |
4.4% |
| Vomiting |
4.4% |
| Flushing |
3.6% |
| Hypertension |
3.6% |
| Hypoaesthesia |
3.6% |
| Paraesthesia |
3.6% |
| Altered State Of Consciousness |
2.9% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
100.0% |
|
| Drug Interaction |
71.4% |
| Rhabdomyolysis |
28.6% |
|
